Tocqueville Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,000
Closed -$341K 741
2020
Q4
$341K Hold
2,000
0.01% 599
2020
Q3
$281K Hold
2,000
0.01% 580
2020
Q2
$321K Buy
+2,000
New +$272K 0.01% 550
2020
Q1
Sell
-2,000
Closed -$258K 711
2019
Q4
$258K Sell
2,000
-1,000
-33% -$101K ﹤0.01% 665
2019
Q3
$226K Sell
3,000
-41,845
-93% -$4.94M ﹤0.01% 698
2019
Q2
$6.81M Sell
44,845
-42,810
-49% -$5.2M 0.09% 238
2019
Q1
$10.4M Buy
87,655
+33,150
+61% +$4.26M 0.14% 179
2018
Q4
$5.95M Sell
54,505
-10,280
-16% -$1.29M 0.09% 233
2018
Q3
$10.5M Buy
64,785
+33,810
+109% +$4.62M 0.13% 187
2018
Q2
$4.09M Buy
30,975
+900
+3% +$84.9K 0.05% 341
2018
Q1
$2.23M Buy
30,075
+500
+2% +$33.3K 0.03% 421
2017
Q4
$1.65M Buy
+29,575
New +$1.57M 0.02% 454
2014
Q3
Sell
-3,200
Closed -$95K 1225
2014
Q2
$95K Sell
3,200
-12,000
-79% -$379K ﹤0.01% 1165
2014
Q1
$365K Sell
15,200
-300
-2% -$7.65K ﹤0.01% 647
2013
Q4
$316K Buy
15,500
+1,200
+8% +$35.7K ﹤0.01% 699
2013
Q3
$675K Sell
14,300
-4,650
-25% -$179K 0.01% 578
2013
Q2
$721K Buy
+18,950
New +$678K 0.01% 565

Other funds holding SRPT

Tocqueville Asset Management's SRPT Position: Q1 2021 in Review

Tocqueville Asset Management sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 2,000 shares — an estimated $341K sold.

Tocqueville Asset Management first reported a position in SRPT in Q2 2013 and held it in 17 quarters. The position peaked at $10.5M in Q3 2018. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

  • Tocqueville Asset Management reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Tocqueville Asset Management sold 2,000 Sarepta Therapeutics shares in Q1 2021, an estimated $341K.
  • Tocqueville Asset Management first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 17 quarters.
  • Tocqueville Asset Management's Sarepta Therapeutics position peaked at $10.5M in Q3 2018.
  • 366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on Tocqueville Asset Management's 13F filing for Q1 2021, filed 17 May 2021.